RxDoctor Payments Data

Alexander Choi

Internal Medicine · Flushing, NYNPI 1104818640

Payments from drug & device makers

$5,994in general payments, 2019–2025

Across 231 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$1K
  • AbbVie$863
  • Amarin Pharma, Inc.$780
  • Lilly USA, LLC$710
  • Novo Nordisk$507
  • Merck$370
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,983100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,994 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate58$35,328
CreonLipase/Protease/Amylase31$34,518
JardianceEmpagliflozin47$31,768
VascepaIcosapent Ethyl104$25,174
MyrbetriqMirabegron48$22,751
Diclofenac Epolamine21$14,709
JanumetSitagliptin Phos/Metformin Hcl12$10,076
Dexlansoprazole DrDexlansoprazole13$1,842
Icosapent Ethyl16$1,726
SynthroidLevothyroxine Sodium20$1,294
Atorvastatin Calcium219$878
Losartan Potassium131$579
Galantamine Hbr12$552
Amlodipine Besylate190$551
Celecoxib25$401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$370$45,40470 claims
AbbVieCreon, Synthroid$863$35,81151 claims
Boehringer IngelheimJardiance$65$31,76847 claims
Astellas Pharma US IncMyrbetriq$189$22,75148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.

Other internal medicine in Flushing

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →